WGS studies have suggested that TWT melanomas, commonly of the AM subtype, are more likely to have focal amplifications of CCND1, MDM2, KIT, and KRAS [22], as well as CDK4 and CDK6 [19], than non-TWT melanomas. This evidence concerns the gene KRAS and melanoma.